Copyright
©The Author(s) 2022.
World J Diabetes. Dec 15, 2022; 13(12): 1154-1167
Published online Dec 15, 2022. doi: 10.4239/wjd.v13.i12.1154
Published online Dec 15, 2022. doi: 10.4239/wjd.v13.i12.1154
OR | 95%CI | P value | ||
Model 1 | Sex (female vs male) | 0.30 | 0.10-0.93 | 0.038 |
Baseline characteristics | Age (yr) | 1.03 | 0.98-1.09 | 0.28 |
R-square: 14.4% | BMI (kg/m2) | 1.12 | 0.99-1.28 | 0.073 |
Model 2 | Sex (female vs male) | 0.57 | 0.15-2.16 | 0.41 |
Baseline characteristics | Age (yr) | 1.02 | 0.94-1.11 | 0.62 |
R-square: 34.4% | BMI (kg/m2) | 1.14 | 0.96-1.35 | 0.13 |
HbA1c (%) | 0.85 | 0.59-1.23 | 0.39 | |
Baseline eGFR (mL/min/ 1.73 m2 of body surface area) | 1.02 | 0.98-1.07 | 0.28 | |
NLRmax | 1.18 | 1.05-1.33 | 0.007 | |
Model 3 | Sex (female vs male) | 0.42 | 0.09-1.94 | 0.27 |
Baseline characteristics | Age (yr) | 1.08 | 0.97-1.20 | 0.18 |
R-square = 46.9% | BMI (kg/m2) | 1.24 | 1.01-1.53 | 0.040 |
HbA1c (%) | 1.04 | 0.67-1.61 | 0.89 | |
Baseline eGFR (mL/min/1.73 m2 of body surface area) | 1.04 | 0.99-1.09 | 0.12 | |
NLRmax | 1.20 | 1.06-1.37 | 0.005 | |
Albuminuria | 0.09 | 0.01-0.62 | 0.015 |
- Citation: Bashkin A, Shehadeh M, Shbita L, Namoura K, Haiek R, Kuyantseva E, Boulos Y, Yakir O, Kruzel-Davila E. Baseline moderate-range albuminuria is associated with protection against severe COVID-19 pneumonia. World J Diabetes 2022; 13(12): 1154-1167
- URL: https://www.wjgnet.com/1948-9358/full/v13/i12/1154.htm
- DOI: https://dx.doi.org/10.4239/wjd.v13.i12.1154